Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-3000
Dr. Giordano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sara (Barnato) Giordano is an oncology specialist based in Boston, MA, working as a Senior Medical Physician at the Dana-Farber Cancer Institute since 2020. Dr. Giordano completed a fellowship in Hematology and Medical Oncology as well as a residency in Internal Medicine at McGaw Medical Center of Northwestern University. An alum of Loyola University Chicago Stritch School of Medicine, Dr. Giordano has significant experience in breast cancer, clinical research, and medical education. Key publications include works on antibody-drug conjugates and immunotherapy in breast cancer, with many citations reflecting influence in the field. Dr. Giordano has led clinical trials on treatments for breast and prostate cancer and has received CMS Meaningful Use Stage 1 Certifications for various Epic Systems EHR suites.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2006 - 2009
Loyola University Chicago Stritch School of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2020 - 2027
SC State Medical License 2013 - 2021
IL State Medical License 2009 - 2020
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer Start of enrollment: 2013 Mar 01
- Docetaxel and Lycopene in Metastatic Prostate Cancer Start of enrollment: 2013 Nov 01
- Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. Start of enrollment: 2014 Jun 27
Publications & Presentations
PubMed
- 1 citationsAntibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutions.Pooja Patel, Antonio Giordano, Sara Giordano, Ilana Schlam, Sara M Tolaney
NPJ Breast Cancer. 2025-07-30 - 91 citationsImmunotherapy in Breast Cancer.Kathrin Dvir, Sara Giordano, Jose Pablo Leone
International Journal of Molecular Sciences. 2024-07-09 - 14 citationsOncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.Luca Licata, Giulia Viale, Mario Giuliano, Giuseppe Curigliano, Mariana Chavez-MacGregor
NPJ Breast Cancer. 2023-06-08
Press Mentions
Improving Outcomes in Metastatic Breast Cancer Through Novel Therapies and Personalized CareFebruary 13th, 2025
Pregnancy, Breast Cancer, Postpartum Depression: A Charleston Mom Survived Them All in a YearMay 13th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
